» Articles » PMID: 8380214

Distribution Profile and Properties of Peripheral-type Benzodiazepine Receptors on Human Hemopoietic Cells

Overview
Journal Life Sci
Publisher Elsevier
Date 1993 Jan 1
PMID 8380214
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular localization of peripheral-type benzodiazepine receptors (PBRs) was characterized in several human blood cell subpopulations including erythrocytes, platelets, monocytes and polymorphonuclear neutrophils (PMN), B, NK, T8 and T4-cells. Pharmacological properties of the PBR were established by binding studies and PBR mRNA expression was measured by quantitative polymerase chain reaction based method. These data clearly indicate 1) the PBR is pharmacologically homogeneous in the various types of blood cells, 2) the rank order of PBR cell density is monocytes = PMN > lymphocytes >> platelets > erythrocytes, 3) the PBR appears to be transcriptionally regulated since mRNA levels are roughly correlated with PBR density.

Citing Articles

Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.

Pike C, Kim M, Schnitzer K, Mercaldo N, Edwards R, Napadow V BMJ Open. 2022; 12(9):e063613.

PMID: 36123113 PMC: 9486315. DOI: 10.1136/bmjopen-2022-063613.


The cross-sectional association of frailty with chronic past and current use of benzodiazepine drugs.

Gomez C, Quinones A, Gonell A, Sani T, Ysea-Hill O, Baskaran D Aging Clin Exp Res. 2022; 34(8):1837-1843.

PMID: 35522368 DOI: 10.1007/s40520-022-02125-9.


Comparison of Invasive and Non-invasive Estimation of [C]PBR28 Binding in Non-human Primates.

Aceves-Serrano L, Sossi V, Doudet D Mol Imaging Biol. 2021; 24(3):404-415.

PMID: 34622422 DOI: 10.1007/s11307-021-01661-6.


Neuroimmune signatures in chronic low back pain subtypes.

Alshelh Z, Brusaferri L, Saha A, Morrissey E, Knight P, Kim M Brain. 2021; 145(3):1098-1110.

PMID: 34528069 PMC: 9128369. DOI: 10.1093/brain/awab336.


Synthesis and pharmacological evaluation of [F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971.

Mattner F, Katsifis A, Bourdier T, Loch C, Berghofer P, Fookes C RSC Med Chem. 2021; 12(7):1207-1221.

PMID: 34355185 PMC: 8292990. DOI: 10.1039/d1md00035g.